AstraZeneca Wilmington R&D Site To Focus On Central Nervous System Drugs
AstraZeneca's Wilmington, Del. research and development site will focus on developing central nervous system drugs in the restructuring following the merger.
AstraZeneca's Wilmington, Del. research and development site will focus on developing central nervous system drugs in the restructuring following the merger.